Freeman Chris (CIK 1871615) reported 61 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-11). Recent activity: Buy GH (35,412 shares), Buy GH (28,193 shares), Sell GH (3,463 shares), Sell GH (7,365 shares), Sell GH (35,364 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-11 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 35,412 | $3.9M |
| 2026-08-11 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 28,193 | $799,835 |
| 2026-08-11 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 3,463 | $579,639 |
| 2026-08-11 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 7,365 | $1.2M |
| 2026-08-11 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 35,364 | $6.0M |
| 2026-08-11 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 17,413 | $3.0M |
| 2026-07-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,928 | $0 |
| 2026-07-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,667 | $0 |
| 2026-07-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 2,526 | $0 |
| 2026-07-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,293 | $0 |
| 2026-07-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 3,141 | $536,389 |
| 2026-06-16 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 594 | $77,113 |
| 2026-06-16 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,402 | $0 |
| 2026-05-26 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 24,406 | $801,981 |
| 2026-05-26 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 24,406 | $2.9M |
| 2026-04-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,929 | $0 |
| 2026-04-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,667 | $0 |
| 2026-04-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 2,526 | $0 |
| 2026-04-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 5,091 | $0 |
| 2026-04-02 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 4,750 | $432,962 |
| 2026-03-17 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 15,426 | $0 |
| 2026-03-17 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,402 | $0 |
| 2026-03-17 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Sell | 7,127 | $609,287 |
| 2026-01-05 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 1,928 | $0 |
| 2026-01-05 | Guardant Health, Inc. (GH) | Chief Commercial Officer | Buy | 15,428 | $0 |
Source: SEC Form 4 filings · as of 2026-08-11